Disease-causing mutations in the kinase domain and C-terminal noncatalytic region of PINK1 suppress catalytic activity, leading to the hypothesis that restoration of kinase activity may have disease-modifying effects in PD (109). This evidence concerns the gene PINK1 and Parkinson disease.